Pulp And Paper
Health
Medical

American Renal Associates

$9.50
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.23 (-2.36%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell ARA and other stocks, options, ETFs, and crypto commission-free!

About

American Renal Associates Holdings, Inc. operates with interest in providing kidney dialysis services. It also offers outpatient and inpatient dialysis treatments for patients suffering from chronic kidney failure. Read More The company was founded by Joseph A. Carlucci, Christopher T. Ford and Syed T. Kamal in 1999 and is headquartered in Beverly, MA.

Employees
4,692
Headquarters
Beverly, Massachusetts
Founded
1999
Market Cap
308.89M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
163.89K
High Today
$9.73
Low Today
$9.45
Open Price
$9.60
Volume
44.10K
52 Week High
$23.99
52 Week Low
$9.20

Collections

Pulp And Paper
Health
Medical
2016 IPO
US
North America

News

Markets InsiderMar 15

AMERICAN RENAL INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates American Renal Associates Holdings, Inc. for Possible Securities Fraud - ARA

NEW ORLEANS, March 15, 2019 /PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that KSF has commenced an investigation into American Renal Associates Holdings, Inc. (NYSE: ARA) on behalf of shareholders that purchased the Company's shares issued in connection with its April 2016 Initial Public Offering ("IPO"). On March 8, 2019, the Company disclosed that it will delay filing its Form 10-K annual report fo...

80
Associated PressMar 13

Glancy Prongay & Murray LLP Announces Investigation on Behalf of American Renal Associates Holdings, Inc. Investors

This content is a press release from our partner Business Wire. The AP newsroom and editorial departments were not involved in its creation. This content is a press release from our partner Business Wire. The AP newsroom and editorial departments were not involved in its creation. LOS ANGELES--(BUSINESS WIRE)--Mar 13, 2019--Glancy Prongay & Murray LLP (“GPM”) announces an investigation on behalf of American Renal Associates Holdings, Inc. investors (“American Renal” or the “Company”) (NYSE: ARA ) concerni...

14
Yahoo FinanceMar 13

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of American Renal Associates Holdings, Inc. Investors

BENSALEM, Pa.--(BUSINESS WIRE)-- Law Offices of Howard G. Smith announces an investigation on behalf of American Renal Associates Holdings, Inc. investors (“American Renal” or the “Company”) (NYSE: ARA) concerning the Company and its officers’ possible violations of federal securities laws. On March 8, 2019, American Renal announced the postponement of the release of its fourth quarter and year-end 2018 earnings report, as well as the filing of their 2018 Form 10-K. Previously, the SEC had requested in Oc...

3

Earnings

-$0.01
$0.06
$0.13
$0.20
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Estimated
$0.11 per share
Actual
Expected Mar 25
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.